{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:29:42Z","timestamp":1789039782918,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004488","name":"Hrvatska Zaklada za Znanost","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004488","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ejmech.2019.111739","type":"journal-article","created":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T01:42:28Z","timestamp":1569634948000},"page":"111739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Antitumor and antiviral activities of 4-substituted 1,2,3-triazolyl-2,3-dibenzyl-L-ascorbic acid derivatives"],"prefix":"10.1016","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0537-0292","authenticated-orcid":false,"given":"Andrijana Me\u0161\u010di\u0107","family":"Macan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Harej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Cazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Klobu\u010dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vi\u0161nja","family":"Stepani\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kre\u0161imir","family":"Paveli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0491-673X","authenticated-orcid":false,"given":"Sandra Kraljevi\u0107","family":"Paveli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Schols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Snoeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela","family":"Andrei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5021-8970","authenticated-orcid":false,"given":"Silvana","family":"Rai\u0107-Mali\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.111739_bib1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3389\/fonc.2014.00359","article-title":"Ascorbate as a co-factor for fe- and 2-oxoglutarate dependent dioxygenases: physiological activity in tumor growth and progression","volume":"4","author":"Kuiper","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2019.111739_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1476-4598-6-55","article-title":"Sodium ascorbate induces apoptosis in neuroblastoma cell lines by interfering with iron uptake","volume":"6","author":"Carosio","year":"2007","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2019.111739_bib3","doi-asserted-by":"crossref","first-page":"13604","DOI":"10.1073\/pnas.0506390102","article-title":"Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues","volume":"102","author":"Chen","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2019.111739_bib4","doi-asserted-by":"crossref","first-page":"222ra18","DOI":"10.1126\/scitranslmed.3007154","article-title":"High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy","volume":"6","author":"Ma","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2019.111739_bib5","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.freeradbiomed.2012.07.079","article-title":"Enhanced antitumor activity of vitamin C via p53 in Cancer cells","volume":"53","author":"Kim","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2019.111739_bib6","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1126\/science.aaa5004","article-title":"Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH","volume":"350","author":"Yun","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.111739_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.biochi.2017.12.011","article-title":"L-ascorbic acid: a true substrate for HIF prolyl hydroxylase?","volume":"147","author":"Osipyants","year":"2018","journal-title":"Biochimie"},{"key":"10.1016\/j.ejmech.2019.111739_bib8","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.2174\/138161206777698783","article-title":"Natural product-derived small molecule activators of hypoxia-inducible factor-1 (HIF-1)","volume":"12","author":"Nagle","year":"2006","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2019.111739_bib9","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.1066373","article-title":"A\u00a0conserved family of prolyl-4-hydroxylases that modify HIF","volume":"294","author":"Bruick","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.111739_bib10","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.freeradbiomed.2014.01.033","article-title":"Intracellular ascorbate enhances hypoxia-inducible factor (HIF)-hydroxylase activity and preferentially suppresses the HIF-1 transcriptional response","volume":"69","author":"Kuiper","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2019.111739_bib11","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1186\/s12885-015-1878-5","article-title":"Ascorbic acid and ascorbate-2-phosphate decrease HIF activity and malignant properties of human melanoma cells","volume":"15","author":"Miles","year":"2015","journal-title":"BMC Canc."},{"key":"10.1016\/j.ejmech.2019.111739_bib12","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s00018-016-2145-x","article-title":"The epigenetic role of vitamin C in health and disease","volume":"73","author":"Camarena","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2019.111739_bib13","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature12362","article-title":"Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells","volume":"500","author":"Blaschke","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.111739_bib14","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/onc.2012.176","article-title":"SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatment","volume":"32","author":"Hong","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2019.111739_bib15","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1016\/j.bmc.2012.01.054","article-title":"Novel 1,2,4-triazole and imidazole derivatives of l-ascorbic and imino-ascorbic acid: synthesis, anti-HCV and antitumor activity evaluations","volume":"20","author":"Wittine","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111739_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bmc.2004.09.052","article-title":"The novel pyrimidine and purine derivatives of l-ascorbic acid: synthesis, one- and two-dimensional 1H and 13C NMR study, cytostatic and antiviral evaluation","volume":"13","author":"Gazivoda","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111739_bib17","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1021\/jm070324z","article-title":"Synthesis and antiviral and cytostatic evaluations of the new c-5 substituted pyrimidine and furo[2,3-d]pyrimidine 4\u2032,5\u2032-didehydro-L- ascorbic acid derivatives","volume":"50","author":"Gazivoda","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111739_bib18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.carres.2005.12.010","article-title":"Synthesis, structural studies, and cytostatic evaluation of 5,6-di-O-modified L-ascorbic acid derivatives","volume":"341","author":"Gazivoda","year":"2006","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejmech.2019.111739_bib19","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.bmc.2006.10.046","article-title":"The novel C-5 aryl, alkenyl, and alkynyl substituted uracil derivatives of l-ascorbic acid: synthesis, cytostatic, and antiviral activity evaluations","volume":"15","author":"Gazivoda","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111739_bib20","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1359-6446(03)02933-7","article-title":"The growing impact of click chemistry on drug discovery","volume":"8","author":"Kolb","year":"2003","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2019.111739_bib21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejmech.2016.01.005","article-title":"Design, synthesis and biological evaluation of novel l-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors","volume":"110","author":"Wang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111739_bib22","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.bmcl.2013.01.051","article-title":"Aspulvinones from a mangrove rhizosphere soil-derived fungus Aspergillus terreus Gwq-48 with anti-influenza A viral (H1N1) activity","volume":"23","author":"Gao","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111739_bib23","first-page":"197","article-title":"Derivate der L-Ascorbins\u00e4ure 1, Darstellung und Eigenschaften der O2,O3-Ethandiyl- und der O2,O3-Dibenzyl-L-Ascorbins\u00e4uren","volume":"109","author":"Von Dallacker","year":"1985","journal-title":"Chem. Ztg."},{"key":"10.1016\/j.ejmech.2019.111739_bib24","first-page":"277","article-title":"Derivate der L-Ascorbins\u00e4ure 2, Darstellung von Deoxy-L-Ascorbins\u00e4uren","volume":"109","author":"Von Dallacker","year":"1985","journal-title":"Chem. Ztg."},{"key":"10.1016\/j.ejmech.2019.111739_bib25","doi-asserted-by":"crossref","first-page":"10860","DOI":"10.1021\/acs.jmedchem.8b01504","article-title":"4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms IX and XII showing hypoxia-enhanced antiproliferative profiles","volume":"61","author":"Nocentini","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111739_bib26","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.4068","article-title":"An update on anticancer drug development and delivery targeting carbonic anhydrase IX","volume":"5","author":"Kazokait\u0117","year":"2017","journal-title":"PeerJ"},{"key":"10.1016\/j.ejmech.2019.111739_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/01480545.2016.1223095","article-title":"Fluorinated benzenesulfonamide anticancer inhibitors of carbonic anhydrase IX exhibit lower toxic effects on zebrafish embryonic development than ethoxzolamide","volume":"40","author":"Kazokait\u0117","year":"2017","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.ejmech.2019.111739_bib28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejmech.2013.08.048","article-title":"Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety","volume":"69","author":"Al-Dosari","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111739_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.canlet.2010.09.010","article-title":"A\u00a0novel dithiocarbamate analogue with potentially decreased ALDH inhibition has copper-dependent proteasome-inhibitory and apoptosis-inducing activity in human breast cancer cells","volume":"300","author":"Wang","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2019.111739_bib30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1358\/dof.2004.029.04.787236","article-title":"Application of organic carbamates in drug design. Part 1:anticancer agents - recent reports","volume":"29","author":"Ray","year":"2004","journal-title":"Drugs Future"},{"key":"10.1016\/j.ejmech.2019.111739_bib31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1358\/dof.2005.030.02.869228","article-title":"Organic carbamates in drug development. Part II: antimicrobial agents - recent reports","volume":"30","author":"Ray","year":"2005","journal-title":"Drugs Future"},{"key":"10.1016\/j.ejmech.2019.111739_bib32","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ejmech.2016.08.062","article-title":"Synthesis, in\u00a0vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole\u2013coumarin hybrids","volume":"124","author":"Kraljevi\u0107","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111739_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejmech.2012.12.046","article-title":"Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents","volume":"62","author":"Duan","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111739_bib34","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1039\/C6RA25244C","article-title":"Continuous flow-ultrasonic synergy in click reactions for the synthesis of novel 1,2,3-triazolyl appended 4,5-unsaturated l -ascorbic acid derivatives","volume":"7","author":"Me\u0161\u010di\u0107","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2019.111739_bib35","doi-asserted-by":"crossref","unstructured":"C.A. Lipinski, Drug-like properties and the causes of poor solubility and poor permeability, J. Pharmacol. Toxicol. Methods. 44 (n.d.) 235-249. doi:10.1016\/S1056-8719(00)00107-6.","DOI":"10.1016\/S1056-8719(00)00107-6"},{"key":"10.1016\/j.ejmech.2019.111739_bib36","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/ci500588j","article-title":"DataWarrior: an open-source program for chemistry aware data visualization and analysis","volume":"55","author":"Sander","year":"2015","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2019.111739_bib37","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.ejmech.2016.11.028","article-title":"Novel pyrimidine-2,4-dione\u20131,2,3-triazole and furo[2,3-d]pyrimidine-2-one\u20131,2,3-triazole hybrids as potential anti-cancer agents: synthesis, computational and X-ray analysis and biological evaluation","volume":"125","author":"Gregori\u0107","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111739_bib38","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1677\/erc.1.00728","article-title":"Hypoxia-inducible factor-1 in human breast and prostate cancer","volume":"13","author":"Kimbro","year":"2006","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ejmech.2019.111739_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2559.2005.02045.x","article-title":"Hypoxia-inducible factor-1\u03b1 is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer","volume":"46","author":"Bos","year":"2005","journal-title":"Histopathology"},{"key":"10.1016\/j.ejmech.2019.111739_bib40","first-page":"5830","article-title":"Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases","volume":"59","author":"Zhong","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2019.111739_bib41","doi-asserted-by":"crossref","first-page":"R450","DOI":"10.1186\/bcr813","article-title":"Expression of hypoxia-inducible factor-1\u03b1 and cell cycle proteins in invasive breast cancer are estrogen receptor related","volume":"6","author":"Bos","year":"2004","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ejmech.2019.111739_bib42","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.4161\/cc.20717","article-title":"CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth","volume":"11","author":"Capparelli","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejmech.2019.111739_bib43","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ccr.2007.10.001","article-title":"Shaping genetic alterations in human cancer: the p53 mutation paradigm","volume":"12","author":"Soussi","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2019.111739_bib44","first-page":"147","article-title":"Crosstalk between nitric oxide and hypoxia-inducible factor signaling pathways: an update","volume":"5","author":"Poyton","year":"2015","journal-title":"Res. Rep. Biochem."},{"key":"10.1016\/j.ejmech.2019.111739_bib45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.niox.2010.12.010","article-title":"Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease","volume":"25","author":"Olson","year":"2011","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.ejmech.2019.111739_bib46","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/sj.emboj.7600196","article-title":"HIF-1\u03b1 induces cell cycle arrest by functionally counteracting Myc","volume":"23","author":"Koshiji","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2019.111739_bib47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejmech.2014.05.042","article-title":"Synthesis and anticancer activity of \u03b3-(triazolyl ethylidene)butenolides and polyfunctional pyrrolinones","volume":"82","author":"Devender","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111739_bib48","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1021\/ci010132r","article-title":"Reoptimization of MDL keys for use in drug discovery","volume":"42","author":"Durant","year":"2002","journal-title":"J.\u00a0Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.ejmech.2019.111739_bib50","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.1016\/j.bmc.2008.03.074","article-title":"Synthesis, cytostatic and anti-HIV evaluations of the new unsaturated acyclic C-5 pyrimidine nucleoside analogues","volume":"16","author":"Gazivoda","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111739_bib51","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/323464a0","article-title":"A\u00a0novel selective broad-spectrum anti-DNA virus agent","volume":"323","author":"De Clercq","year":"1986","journal-title":"Nature"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419308918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419308918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:57:30Z","timestamp":1759327050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419308918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":50,"alternative-id":["S0223523419308918"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111739","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antitumor and antiviral activities of 4-substituted 1,2,3-triazolyl-2,3-dibenzyl-L-ascorbic acid derivatives","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111739","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111739"}}